RxDoctor Payments Data

Ryan Simmons, MD

Otolaryngology · Tupelo, MSNPI 1548271448

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Sanofi at 27.6% of the total.

$1,592in general payments, 2019–2025

Across 57 payments — averaging $27.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$439
  • Intersect ENT, Inc.$213
  • Aerin Medical Inc.$175
  • Cumberland Pharmaceuticals, Inc.$144
  • Inspire Medical Systems, Inc.$138
  • Regeneron Healthcare Solutions, Inc.$103
  • plus $381 from 12 others

What the payments were for

  • Food & beverage$1,592100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,592 in reported general payments places this provider in the 55th percentile of 97 otolaryngology providers in Mississippi.

See all otolaryngology providers in Mississippi

Medicare billing

Part B allowed, 2024
$218,245
Medicare patients
782
Services billed
2,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide194$5,518
Fluticasone Propionate308$3,799
Famotidine304$2,317
Tobramycin-DexamethasoneTobramycin/Dexamethasone42$1,953
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,541
Cefdinir73$1,263
Omeprazole86$674
Montelukast Sodium103$612
Clotrimazole18$476
Azelastine Hcl27$439
Ofloxacin12$372
Mupirocin37$278
Meclizine Hcl17$198
Doxycycline Hyclate13$197
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$195

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →